UONDDL
CLVS
University of Notre Dame du Lac’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-101,386
| Closed | -$2.52M | – | 75 |
|
|
2019
Q1 | $2.52M | Sell |
101,386
-38,183
| -27% | -$948K | 0.56% | 54 |
|
|
2018
Q4 | $2.51M | Buy |
139,569
+59,128
| +74% | +$1.06M | 0.61% | 46 |
|
|
2018
Q3 | $2.36M | Buy |
80,441
+26,244
| +48% | +$771K | 0.44% | 66 |
|
|
2018
Q2 | $2.46M | Buy |
54,197
+10,436
| +24% | +$474K | 0.48% | 60 |
|
|
2018
Q1 | $2.31M | Buy |
43,761
+3,772
| +9% | +$199K | 0.43% | 69 |
|
|
2017
Q4 | $2.72M | Buy |
39,989
+3,460
| +9% | +$235K | 0.56% | 59 |
|
|
2017
Q3 | $3.01M | Sell |
36,529
-14,366
| -28% | -$1.18M | 0.84% | 55 |
|
|
2017
Q2 | $4.77M | Buy |
50,895
+9,270
| +22% | +$868K | 1.41% | 17 |
|
|
2017
Q1 | $2.65M | Buy |
+41,625
| New | +$2.65M | 0.66% | 54 |
|